1. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Diabetic Neuropathy.2024.
2. Korada et al. A single blinded randomized controlled trial assessing the effect ofphotobiomodulation therapy on neuron specific biomarkers in type II diabetes mellitus patientswith peripheral neuropathy. 2025.
3. Korada HY, et al. Effect of Novel Laser Shoe Photobiomodulation on Neuropathic Pain in Type 2Diabetes Mellitus. 2024.
4. Chamkouri H, et al. Photobiomodulation combination therapy as a new insight in neurologicaldisorders: a comprehensive systematic review. BMC Neurology. 2024.
5. Mohamadi M, et al. Enhancing nerve regeneration in infraorbital nerve injury rat model: effects ofvitamin B complex and photobiomodulation. Lasers in Medical Science. 2024.
6. Martins D, et al. Photobiomodulation Therapy in Neuropathic Pain: Mechanisms, Evidence, andFuture Directions. Frontiers in Photonics. 2025.
7. Korada HY, et al. Effectiveness of Photobiomodulation Therapy on Neuropathic Pain, NerveConduction and Plantar Pressure Distribution in Diabetic Peripheral Neuropathy - A SystematicReview. Current Diabetes Reviews. 2023.
8. da Silva Leal MV, et al. Effect of photobiomodulation on neuropathic pain of diabetic origin: anarrative review of the literature. 2023.
9. Holanda VM, et al. The use of low-level laser therapy (LLLT) for pain relief in neuropathic pain.Rev Dor. 2016.
10. de Andrade AL, et al. The effect of photobiomodulation therapy on diabetic neuropathic pain.Lasers Med Sci. 2019.
11. Khodaeian M, et al. The effect of visible and infra-red light on diabetic peripheral neuropathy. JLasers Med Sci. 2023.
12. Khamseh ME, et al. Diabetic peripheral neuropathy: a narrative review on treatment withphotobiomodulation. J Diabetes Metab Disord. 2014.
13. Ishiguro M, Ikeda K, Tomita K. Effect of near-infrared light-emitting diodes on nerve regeneration.J Orthop Sci. 2010.
14. Moncrieff L, et al. Low-intensity LASER and LED (PBMT) for pain control of musculoskeletalconditions. PMC. 2024.
15. Argenta PA, et al. The effect of photobiomodulation on chemotherapy-induced peripheralneuropathy: a randomized, sham-controlled clinical trial. Gynecol Oncol. 2017.
16. Lodewijckx J, et al. The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial. Support Care Cancer.2022.
17. Robijns J, et al. Photobiomodulation Therapy for the Management of Chemotherapy-InducedPeripheral Neuropathy: An Overview. 2020.
18. Navratil L, Kymplova J. Phototherapy of neuropathic pain in trigeminal neuralgia. J Lasers MedSci. 2019.
19. Hamblin MR. Biological Effects of Low Level Laser Therapy. PMC. 2015.
20. Hashmi JT, et al. Role of low-level laser therapy in neurorehabilitation. PMC. 2010.
21. Ferraresi C, et al. Low-level laser (light) therapy increases mitochondrial membrane potential andATP synthesis in C2C12 myotubes with a peak response at 3-6 hours. PMC. 2015.
22. Cho GM, et al. Photobiomodulation (660 nm) therapy reduces oxidative stress and induces BDNFexpression in the hippocampus. 2019.
23. Hamblin MR. Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy. PMC.2017.
24. Wang JY, et al. Low level light therapy/photobiomodulation for diabetic peripheral neuropathy:Protocol of a systematic review and meta-analysis. PMC. 2022.